Literature DB >> 101462

Role of antibody and complement in opsonization of group B streptococci.

A O Shigeoka, R T Hall, V G Hemming, C D Allred, H R Hill.   

Abstract

A requirement for the classic complement pathway in opsonization of group B streptococci was observed by using both a chemiluminescence and a radiolabeled bacterial uptake technique. The classic pathway increased levels of opsonization for types Ia and II stock and wild strains and for some type III wild strains. In contrast, other type III wild strains and the type III stock strain had accelerated kinetics of uptake in the presence of an intact classic pathway, but the level of opsonization was unchanged from that with antibody alone. We could not demonstrate a significant role for the alternative pathway in opsonizing stock or wild strains of group B streptococci. Futhermore, electrophoretic and complement consumption analysis by hemolytic titration failed to reveal alternative pathway activation by the majority of strains of this group. Therapy aimed at supplying opsonins for these organisms will require the presence of type-specific antibody.

Mesh:

Substances:

Year:  1978        PMID: 101462      PMCID: PMC421953          DOI: 10.1128/iai.21.1.34-40.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  Pneumococcal type-associated variability in alternate complement pathway activation.

Authors:  D P Fine
Journal:  Infect Immun       Date:  1975-10       Impact factor: 3.441

2.  Effect of temperature on phagocytosis by human polymorphonuclear neutrophils.

Authors:  G L Mandell
Journal:  Infect Immun       Date:  1975-07       Impact factor: 3.441

3.  NEONATAL SEPSIS AND OTHER INFECTIONS DUE TO GROUP B BETA-HEMOLYTIC STREPTOCOCCI.

Authors:  T C EICKHOFF; J O KLEIN; A K DALY; D INGALL; M FINLAND
Journal:  N Engl J Med       Date:  1964-12-10       Impact factor: 91.245

Review 4.  Phagocytosis: recognition and ingestion.

Authors:  T P Stossel
Journal:  Semin Hematol       Date:  1975-01       Impact factor: 3.851

5.  Group B streptococcal neonatal and infant infections.

Authors:  R A Franciosi; J D Knostman; R A Zimmerman
Journal:  J Pediatr       Date:  1973-04       Impact factor: 4.406

6.  The spectrum of group B streptococcal infections in infancy.

Authors:  J B Howard; G H McCracken
Journal:  Am J Dis Child       Date:  1974-12

7.  Neutrophil receptors for IgG and complement: their roles in the attachment and ingestion phases of phagocytosis.

Authors:  D J Scribner; D Fahrney
Journal:  J Immunol       Date:  1976-04       Impact factor: 5.422

8.  Evaluation of nonspecific (alternative pathway) opsonic activity by neutrophil chemiluminescence.

Authors:  H R Hill; N A Hogan; J F Bale; V G Hemming
Journal:  Int Arch Allergy Appl Immunol       Date:  1977

9.  Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens.

Authors:  R C Lancefield; M McCarty; W N Everly
Journal:  J Exp Med       Date:  1975-07-01       Impact factor: 14.307

10.  The enhancement of bacterial phagocytosis by serum. The role of complement components and two cofactors.

Authors:  R B Johnston; M R Klemperer; C A Alper; F S Rosen
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

View more
  22 in total

1.  Deposition and degradation of C3 on type III group B streptococci.

Authors:  J R Campbell; C J Baker; M S Edwards
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

2.  Entry and intracellular survival of group B streptococci in J774 macrophages.

Authors:  P Valentin-Weigand; P Benkel; M Rohde; G S Chhatwal
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

3.  Strain specificity of opsonins for group B streptococci types II and III.

Authors:  A O Shigeoka; R T Hall; H R Hill
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

4.  Immunoprophylaxis and immunotherapy of neonatal group B streptococcal infections.

Authors:  S P Gotoff
Journal:  Infection       Date:  1985       Impact factor: 3.553

5.  Penicillin-binding protein 1a promotes resistance of group B streptococcus to antimicrobial peptides.

Authors:  Andrea Hamilton; David L Popham; David J Carl; Xavier Lauth; Victor Nizet; Amanda L Jones
Journal:  Infect Immun       Date:  2006-11       Impact factor: 3.441

6.  Capsular polysaccharide regulates neutrophil complement receptor interactions with type III group B streptococci.

Authors:  M S Edwards; M R Wessels; C J Baker
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

7.  Impaired opsonophagocytosis of serotypes Ib and II of group B streptococci as compared with serotypes Ia and III: role of the alternative pathway of complement in opsonisation of serotype III of group B streptococci.

Authors:  P Hindocha; R Hill; C B Wood; U Patel; G Hunt
Journal:  J Clin Pathol       Date:  1984-07       Impact factor: 3.411

8.  Immunoprophylaxis and immunotherapy of neonatal group B streptococcal infections.

Authors:  S P Gotoff
Journal:  Infection       Date:  1984 Mar-Apr       Impact factor: 3.553

9.  Association of type- and group-specific antigens with the cell wall of serotype III group B streptococcus.

Authors:  T I Doran; S J Mattingly
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

10.  Effect of differences in antibody and complement requirements on phagocytic uptake and intracellular killing of "c" protein-positive and -negative strains of type II group B streptococci.

Authors:  N R Payne; Y K Kim; P Ferrieri
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.